Psilocybin Mushrooms

Product Overview

ÆTHER psilocybin mushrooms are available in three preparations: raw dried mushrooms, precisely measured capsules, and handmade edible preparations. All formats contain whole fruiting body material from the same stock — the preparation differs, not the medicine. Intended for intentional use in a safe and supportive environment by adults 21 years of age or older only. Psilocybin is a long-duration psychedelic with a well-established safety profile in clinical settings. Approach thoughtfully — set and setting are among the most significant determinants of experience quality.

Potential Benefits

Psilocybin is among the most clinically researched psychedelics and has received FDA Breakthrough Therapy designation for both treatment-resistant depression (2018) and major depressive disorder (2019). A landmark 2006 study by Roland Griffiths at Johns Hopkins found that a single session produced mystical experiences participants rated among the most meaningful of their lives, with lasting improvements in mood and wellbeing. More recent trials report 70–80% response rates for treatment-resistant depression — from a single session — with effects persisting for months. Efficacy has also been demonstrated for tobacco addiction, alcohol use disorder, end-of-life anxiety, and OCD.

Spiritual Significance

Psilocybin mushrooms carry one of the deepest ceremonial histories of any psychoactive substance. Stone mushroom effigies from Mesoamerican cultures date to 1000 BCE. The Mazatec people of Oaxaca, Mexico — whose curandera María Sabina became the most celebrated practitioner of mushroom ceremony in the modern era — preserved an unbroken healing tradition in which the mushrooms, called teonanácatl ("flesh of the gods"), were understood as living medicine and divine intermediaries. The ceremony as practiced by Sabina and her lineage was not ritual in the modern sense — it was direct communion with a living intelligence that dwelt within the mushrooms and spoke through the healer for the benefit of those in need.

R. Gordon Wasson's 1957 LIFE magazine account of participating in one of Sabina's ceremonies — the first such published account by a Westerner — ignited global interest and set off the first wave of psychedelic research. The Good Friday Experiment of 1962, in which divinity students given psilocybin reported full mystical experiences indistinguishable from the peak experiences of history's great mystics, and a 25-year follow-up that confirmed the experiences remained among the most meaningful of their lives, established psilocybin as a reliable entheogen — a substance that genuinely produces what mystics describe as sacred encounter.

Neuroscientist Robin Carhart-Harris's research has given this a mechanistic dimension: psilocybin dramatically suppresses the Default Mode Network — the brain's system of self-referential processing, the neural substrate of the ego. Its silencing corresponds precisely with the dissolution of the ordinary sense of self that mystics have described, across all traditions, as the gateway to genuine spiritual experience. Whether understood through the lens of neuroscience, anthropology, or direct practice, psilocybin has earned its place at the center of a global conversation about the nature of consciousness, healing, and what it means to be fully human.

Available Species

ÆTHER sources and prepares multiple Psilocybe species. All produce the same active compounds — psilocybin and psilocin — but differ in potency, growth characteristics, and subtle experiential qualities. Dosing ranges on this page are calibrated to Psilocybe cubensis as the standard reference. When trying a new species for the first time, always begin at the lower end of your intended dose range and allow full onset before assessing.

Dosing Guide

Doses below are given in grams of dried mushroom and are calibrated to Psilocybe cubensis. If using natalensis or ochraceocentrada, reduce your intended dose by 25–30% until your sensitivity to that species is established. Potency also varies between batches and flushes — begin conservatively with any new supply. Allow at least 90 minutes after ingestion before concluding the experience has not onset.

Potency varies significantly between batches and strains. Starting low on a new supply is always prudent. Never redose before full onset — psilocybin's delayed onset (up to 90 minutes) has led many people to take additional doses prematurely, resulting in an overwhelming experience.

Set & Setting

Set (mindset) and setting (environment) are the primary determinants of psilocybin experience quality — more so than dose. A comfortable, familiar, and safe environment; a clear intention; and a trusted guide or companion are the foundations of a positive experience. Difficult experiences are more common in chaotic, unfamiliar, or socially demanding environments.

Ingredients

Dried Psilocybe mushrooms (cubensis, natalensis, or ochraceocentrada — species labeled on packaging)
Capsule format: Hydroxypropyl methylcellulose (HPMC — vegan)
Edible format: Ingredients listed on packaging

Does not contain artificial additives, fillers, preservatives, or adulterants. Species and preparation format are clearly labeled on all packaging.

Storage & Handling

Warnings

Emergency Contact

Legal Disclaimer

Purchaser assumes all responsibility for legal compliance and proper use. Manufacturer is not responsible for misuse, improper storage, use inconsistent with provided safety guidance, adverse reaction whether foreseeable or unforeseeable, allergic reaction, or unauthorized use.

Not evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Manufactured By

Managing a Drug Crisis

If someone using this substance is in distress, our harm reduction guide covers crisis assessment, life-threatening response protocols, psychological crisis support, naloxone, Michigan medical amnesty, and integration.